Abstract
Proviral integration Moloney virus (PIM) kinases (PIM1, 2 and 3) are overexpressed in several tumour types and contribute to oncogenesis. AZD1208 is a potent ATP-competitive PIM kinase inhibitor investigated in patients with recurrent or refractory acute myeloid leukaemia (AML) or advanced solid tumours. Two dose-escalation studies were performed to evaluate the safety and tolerability, and to define the maximum tolerated dose (MTD), of AZD1208 in AML and solid tumours. Secondary objectives were to evaluate the pharmacokinetics, pharmacodynamics (PD) and preliminary efficacy of AZD1208. Sixty-seven patients received treatment: 32 in the AML study over a 120-900 mg dose range, and 25 in the solid tumour study over a 120-800 mg dose range. Nearly all patients (98.5%) in both studies experienced adverse events, mostly gastrointestinal (92.5%). Dose-limiting toxicities included rash, fatigue and vomiting. AZD1208 was not tolerated at 900 mg, and the protocol-defined MTD was not confirmed. AZD1208 increased CYP3A4 activity after multiple dosing, resulting in increased drug clearance. There were no clinical responses; PD analysis showed biological activity of AZD1208. Despite the lack of single-agent clinical efficacy with AZD1208, P...Continue Reading
References
Feb 24, 1989·Cell·M van LohuizenA Berns
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R AmsonA Telerman
May 1, 1984·Cell·H T CuypersA Berns
Nov 15, 2002·Biochimica Et Biophysica Acta·Zeping WangNancy S Magnuson
Jun 7, 2003·Blood·Hagop KantarjianEmil J Freireich
Sep 5, 2003·The Journal of Biological Chemistry·Bin YanMichael Lilly
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards
Jul 29, 2004·FEBS Letters·Teija L T AhoPäivi J Koskinen
Aug 5, 2004·Leukemia & Lymphoma·Amos M CohenJeremy Don
May 7, 2005·European Journal of Haematology·Christian Bjørn PoulsenElisabeth Ralfkiaer
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey M SkolnikPeter C Adamson
Aug 22, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nilesh ShahManuel Salto-Tellez
Dec 15, 2010·Nature Reviews. Cancer·Martijn C NawijnAnton Berns
Apr 9, 2011·Leukemia·J AsanoM Abe
Jun 26, 2012·Bioorganic & Medicinal Chemistry Letters·Les A DakinXiaolan Zheng
Jan 29, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wanyeon KimBuHyun Youn
Jun 14, 2013·Cancer Biology & Therapy·Dapeng XuAntonio T Baines
Dec 24, 2013·Blood·Erika K KeetonDennis Huszar
Jun 7, 2014·Blood·Shaji K KumarRuben Niesvizky
Aug 16, 2014·Blood·Lisa S ChenVarsha Gandhi
Apr 8, 2016·Leukemia & Lymphoma·Lisa S ChenVarsha Gandhi
Citations
Dec 4, 2019·British Journal of Cancer·Paniz Tavakoli ShiraziDeborah L White
May 11, 2019·Oncotarget·Fabiola Cervantes-GomezVarsha Gandhi
Apr 23, 2020·Clinical Pharmacology and Therapeutics·Delilah F G HendriksMagnus Ingelman-Sundberg
Jul 30, 2020·Leukemia & Lymphoma·Grace GiffordGiles Best
Sep 24, 2020·Future Oncology·Athanasios Mavratzas, Frederik Marmé
Feb 12, 2020·Oncogene·Sean P KennedyBryan T Hennessy
Sep 3, 2020·Scientific Reports·Sabina LuszczakSusan Heavey
Oct 30, 2018·Journal of Cancer Prevention·Xinning ZhangZhen-Zhen Liu
Apr 25, 2019·Nature Communications·Kei MiyakawaAkihide Ryo
Jul 24, 2020·International Journal of Molecular Sciences·Hye Suk BaekShin Kim
Feb 7, 2020·Signal Transduction and Targeted Therapy·Sabina LuszczakSusan Heavey
Aug 28, 2020·Expert Opinion on Therapeutic Targets·Pavel Klener
Nov 30, 2019·Nature Communications·Ricky M TriggSuzanne D Turner
Sep 26, 2020·Nucleic Acids Research·Derrick J Y TanAnh Tuân Phan
Dec 12, 2020·Molecular Cancer Therapeutics·Rachel K Toth, Noel A Warfel
Jun 26, 2020·IScience·Yanan LiYukun Cui
Feb 11, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bruno OyallonCaroline Denevault-Sabourin
Apr 17, 2020·Signal Transduction and Targeted Therapy·Sabina LuszczakSusan Heavey
Feb 14, 2021·Cancer Immunology Research·Gang XinWeiguo Cui
May 1, 2021·Cancers·Katie DunphyPeter O'Gorman
Jul 26, 2021·Bioorganic Chemistry·Mostafa M M El-MiligyAly A Hazzaa
Jul 15, 2021·Nature Communications·Olivia J JamesMahima Swamy
Mar 30, 2021·Arthritis & Rheumatology·Nicola J ManeyArthur G Pratt
Apr 17, 2020·Journal of Medicinal Chemistry·Theresa D ManzNathanael S Gray
Aug 30, 2021·Biochimica Et Biophysica Acta. General Subjects·Aanchal RathiMd Imtaiyaz Hassan
Nov 7, 2021·Leukemia·Avik DuttaGolam Mohi